AVIENCE BIOMEDICALS (AVIENCE-SM) Share Price Falls 8.27% Today

AVIENCE BIOMEDICALS Share Price fell to Rs 353.5 today, down 8.27% from the previous close of Rs 385.35. The move erased Rs 31.85 in a single session and placed the micro-cap healthcare stock among the closely watched decliners of the day. At the time of the snapshot, the company’s market capitalisation stood at Rs 211.37 crore.

The available market data confirms the decline but does not assign any company-specific reason for it. What the numbers do show is a session that weakened immediately after the open: the stock opened at Rs 392, that level also marked the day’s high, and the price later slipped to Rs 353.5, which was also the day’s low. Turnover for the session stood at Rs 1.06 crore.

That combination makes the stock worth tracking from both a trading and valuation perspective. The company operates in the Healthcare sector under the Medical Equipment/Supplies/Accessories industry, so the day’s fall can also be assessed against sector benchmarks, peer valuation multiples and profitability metrics rather than on price movement alone.

AVIENCE BIOMEDICALS (AVIENCE-SM) Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 353.5
Previous Close	Rs 385.35
Today's Move	-Rs 31.85 (-8.27%)
Open	Rs 392
High	Rs 392
Low	Rs 353.5
Turnover	Rs 1.06 crore
Market Capitalisation	Rs 211.37 crore
Market Cap Category	Micro Cap

AVIENCE BIOMEDICALS Share Price Today reflects a distinctly weak session. Because the opening price of Rs 392 was also the day’s high, sellers had the upper hand from the start. The stock then moved steadily lower until it touched Rs 353.5, matching the day’s low at the snapshot point. This kind of open-high to low-end pattern usually signals sustained intraday pressure rather than a brief pullback.

The difference between the day’s high and low was Rs 38.5, which is a meaningful intraday range for a micro-cap counter. With turnover at Rs 1.06 crore, the move was not simply about a marginal tick lower; it was a notable session in percentage as well as absolute terms. Since the price was sitting at the session low in the supplied data, near-term market attention naturally intensified.

For readers following stock updates closely, the important point is that the supplied snapshot offers verified price levels but not a confirmed trigger. That means any interpretation of the move should stay grounded in observed data: the fall from the previous close, the weak intraday structure and the stock’s position within its industry.

AVIENCE BIOMEDICALS (AVIENCE-SM) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 211.37 crore
P/E Ratio	24.15x
P/B Ratio	3.99x
ROE	49.9%
ROCE	34.16%
EPS	Rs 15.96
Book Value Per Share	Rs 96.66
Dividend Yield	0%

The company’s valuation snapshot shows a P/E ratio of 24.15 and a P/B ratio of 3.99. EPS is Rs 15.96 and book value per share is Rs 96.66. On the surface, that places the stock in a moderate earnings-multiple zone relative to many healthcare names, while its price-to-book multiple suggests the market values it above book value but not at an extreme end of the industry range.

The more striking part of the data is profitability. ROE stands at 49.9% and ROCE at 34.16%, both strong by absolute standards and also strong versus the same-industry benchmark set supplied for this article. These return ratios indicate that, based on the available figures, the company screens well on capital efficiency even though the stock fell sharply in today’s session.

Dividend yield is 0%, so the current data set points more toward an earnings and efficiency profile than an income profile. That does not remove price volatility, especially in a micro-cap stock, but it does mean the market has fundamentals to compare against the day’s decline. For anyone evaluating the stock beyond the headline move, the valuation-versus-profitability balance is central.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Industry	Medical Equipment/Supplies/Accessories
Benchmark Scope	same industry
Company P/E Ratio	24.15x
Benchmark Median P/E	33.35x
Benchmark Average P/E	88.8x
Benchmark P/E Range	7.5x to 1,004.34x
Company P/B Ratio	3.99x
Benchmark Median P/B	3.5x
Benchmark Average P/B	3.76x
Company ROE	49.9%
Benchmark Median ROE	15.01%
Benchmark Average ROE	16.46%
Company ROCE	34.16%
Benchmark Median ROCE	16.41%
Benchmark Average ROCE	17.8%
Company Market Capitalisation	Rs 211.37 crore
Benchmark Median Market Cap	Rs 193.06 crore
Benchmark Average Market Cap	Rs 6,526.9 crore

AVIENCE BIOMEDICALS Share Price is easier to interpret when set against its industry data. In the Medical Equipment/Supplies/Accessories segment, the company’s P/E of 24.15 is below the benchmark median of 33.35 and well below the benchmark average of 88.8. The industry range is very wide, stretching from 7.5 to 1,004.34, so average values are influenced by outliers.

On P/B, the company’s 3.99 multiple is slightly above the benchmark median of 3.5 and also above the average of 3.76. That suggests the stock is not especially cheap on book value compared with the full industry sample, but it is also far below the high end of the peer range.

Profitability is where the company stands out the most. ROE of 49.9% compares with an industry median of 15.01% and average of 16.46%, while ROCE of 34.16% compares with a median of 16.41% and average of 17.8%. Meanwhile, the market cap of Rs 211.37 crore is close to the benchmark median of Rs 193.06 crore, though far smaller than the industry average of Rs 6,526.9 crore because that average includes much larger players. In short, the stock fell in a session where its underlying return profile still screens strongly within the industry set.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
LENSKART SOLUTIONS	LENSKART	1,18,577.2	180.93	13.26	6.85	12.55
Poly Medicure	POLYMED	17,610.03	55.89	5.53	10.94	14.05
Q-LINE BIOTECH	QLINE	1,694.09	30.4	3.47	25.55	22.23
3B Blackbio Dx	3BBLACKBIO	1,222.13	22.01	4.36	19.41	26.03
LAXMI DENTAL	LAXMIDENTL	1,111.32	35.98	4.39	21.4	24.97

The peer set shows how different size and valuation can be inside the same industry. Lenskart Solutions carries a market cap of Rs 1,18,577.2 crore, trades at 180.93 times earnings and 13.26 times book, and reports ROE of 6.85% with ROCE of 12.55%. Poly Medicure is at Rs 17,610.03 crore market cap with P/E of 55.89, P/B of 5.53, ROE of 10.94% and ROCE of 14.05%.

Among the smaller listed peers, Q-LINE Biotech trades at a P/E of 30.4 and P/B of 3.47 with ROE of 25.55% and ROCE of 22.23%. 3B Blackbio Dx stands at 22.01 times earnings and 4.36 times book with ROE of 19.41% and ROCE of 26.03%. Laxmi Dental is valued at 35.98 times earnings and 4.39 times book, while reporting ROE of 21.4% and ROCE of 24.97%.

Against this group, AVIENCE BIOMEDICALS Share Price looks lower than several peers on P/E and roughly in the same zone as some peers on P/B. Its ROE of 49.9% and ROCE of 34.16% are higher than all five named comparables in the supplied list. The clear trade-off is company size: at Rs 211.37 crore, it is much smaller than these peers, and smaller companies can see sharper day-to-day price swings.

Why Investors Are Watching AVIENCE BIOMEDICALS

• The stock fell 8.27% to Rs 353.5, a notable one-day decline from Rs 385.35.
• The opening price of Rs 392 was also the session high, and the stock later moved down to Rs 353.5, the day’s low.
• Turnover of Rs 1.06 crore indicates active market participation for the session snapshot.
• The company’s P/E of 24.15 is below the same-industry median of 33.35.
• ROE of 49.9% and ROCE of 34.16% are comfortably above sector benchmark medians and above the named peer set supplied here.
• Its micro-cap size can make price movements more pronounced than in larger healthcare names.

About AVIENCE BIOMEDICALS

AVIENCE BIOMEDICALS is classified in the Healthcare sector and the Medical Equipment/Supplies/Accessories industry. The supplied benchmark universe for this article covers 22 companies in the same industry and shows a broad spread in size, valuation and returns.

That context matters because investors often judge micro-cap stocks through relative positioning as much as through standalone numbers. In this case, the company sits near the industry median market-cap level, below the median P/E, slightly above the median P/B, and well above the median on ROE and ROCE. Those facts help explain why the stock can remain in focus even on a day when the price moves sharply lower.

Track AVIENCE BIOMEDICALS Share Price on Univest

UseUnivest top decliners screener,Univest market blogsto review live stock data, top decliners and related market analysis.

These pages help readers monitor price action, valuation ratios, profitability data and peer context in one place, which is especially useful when a stock records a sharp single-session move.

Frequently Asked Questions

Why did AVIENCE BIOMEDICALS Share Price fall today?

Ans. AVIENCE BIOMEDICALS Share Price fell 8.27% to Rs 353.5 from the previous close of Rs 385.35. The supplied data confirms the decline, but it does not establish a company-specific catalyst behind the move.

What is the current price of the stock?

Ans. At the time of the supplied snapshot, the stock was trading at Rs 353.5, down Rs 31.85 for the day. The previous close was Rs 385.35. The stock moved 8.27% lower during the session.

How did the stock trade during the session?

Ans. The stock opened at Rs 392, which was also the day’s high, and later moved down to Rs 353.5, the day’s low. That pattern indicates sustained weakness through the session.

How does its valuation compare with the industry?

Ans. The P/E ratio of 24.15 is below the same-industry median of 33.35, while the P/B ratio of 3.99 is slightly above the industry median of 3.5. The peer average P/E is 88.8x.

How does the company compare with peers?

Ans. Its P/E is below several named peers such as Poly Medicure and Laxmi Dental, while its ROE and ROCE are higher than all five peers listed in the supplied comparison set.